Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP56675.RAZj05ezlJhV-I9ZT2FHI4QPoGViq3UQp3mN9glupI8m0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP56675.RAZj05ezlJhV-I9ZT2FHI4QPoGViq3UQp3mN9glupI8m0130_assertion type Assertion NP56675.RAZj05ezlJhV-I9ZT2FHI4QPoGViq3UQp3mN9glupI8m0130_head.
- NP56675.RAZj05ezlJhV-I9ZT2FHI4QPoGViq3UQp3mN9glupI8m0130_assertion description "[Po-husk, apart from lowering LDL-C, also reduced TG, TG related to certain gene variants, TC, Apo B-100, oxLDL, insulin-resistance and systolic BP in mild-moderate hypercholesterolaemic individuals. Thus, the target patients to receive Po-husk would be th]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP56675.RAZj05ezlJhV-I9ZT2FHI4QPoGViq3UQp3mN9glupI8m0130_provenance.
- NP56675.RAZj05ezlJhV-I9ZT2FHI4QPoGViq3UQp3mN9glupI8m0130_assertion evidence source_evidence_literature NP56675.RAZj05ezlJhV-I9ZT2FHI4QPoGViq3UQp3mN9glupI8m0130_provenance.
- NP56675.RAZj05ezlJhV-I9ZT2FHI4QPoGViq3UQp3mN9glupI8m0130_assertion SIO_000772 20413122 NP56675.RAZj05ezlJhV-I9ZT2FHI4QPoGViq3UQp3mN9glupI8m0130_provenance.
- NP56675.RAZj05ezlJhV-I9ZT2FHI4QPoGViq3UQp3mN9glupI8m0130_assertion wasDerivedFrom gad-20150221 NP56675.RAZj05ezlJhV-I9ZT2FHI4QPoGViq3UQp3mN9glupI8m0130_provenance.
- NP56675.RAZj05ezlJhV-I9ZT2FHI4QPoGViq3UQp3mN9glupI8m0130_assertion wasGeneratedBy ECO_0000203 NP56675.RAZj05ezlJhV-I9ZT2FHI4QPoGViq3UQp3mN9glupI8m0130_provenance.